Clinical trial
Noninvasive Screening for Fetal Chromosomal Aneuploidy and Abnormality: Assay Development & Optimization in Affected Pregnancies
NCT01052688 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Screening for Fetal Chromosomal Aneuploidy and Abnormality: Assay Development & Optimization in Affected Pregnancies
- Lead sponsor
- Sequenom, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- August 31, 2021
- Enrollment
- 150 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.